Introduction
Normal subjects demonstrate the presence of ultradian oscillations (period 80-150 min) in insulin secretion rate (ISR) tightly coupled to glucose oscillations of similar period. These oscillations appear to be a function of the feedback loop linking glucose and insulin. The present study was undertaken to determine whether the control by glucose of the ultradian oscillations in insulin secretion is altered in impaired glucose tolerance IGT and in non-insulin-dependent diabetes mellitus (NIDDM). Patients with NIDDM (a = 7), IGT (a = 4), and matched nondiabetic controls (a = 5) were studied under three separate protocols that involved administration of glucose at either a constant rate of 6 mg/kg per min for 28 h or in one of two oscillatory patterns at the same overall mean rate. The amplitude of the oscillations was 33% above and below the mean infusion rate, and their respective periods were 144 min (slow oscillatory infusion) or 96 min (rapid oscillatory infusion). Insulin, C-peptide, and glucose were sampled at 10-min intervals during the last 24 h of each study. ISRs were calculated by deconvolution of C-peptide levels. Analysis of the data showed that (a) the tight temporal coupling between glucose and ISR in the nondiabetic controls was impaired in the IGT and NIDDM groups as demonstrated by pulse analysis, crosscorrelation analysis, and spectral analysis; (b) the absolute amplitude ofthe ISR pulses progressively declined with the transition from obesity to IGT to NIDDM; and (c) the absolute amplitude of the ISR oscillations failed to increase appropriately with increasing absolute amplitude ofglucose oscillations in the IGT and NIDDM subjects compared with the control group. In conclusion, the present study demonstrates that important dynamic properties of the feedback loop linking insulin secretion and glucose are disrupted not only in established NIDDM but also in conditions where glucose tolerance is only minimally impaired. Further studies are needed to determine how early in the course of beta-cell dysfunction this lack of control by glucose of the ultradian oscillations in insulin secretion occurs and to define more precisely if this phenomenon plays a pathogenetic role in the onset of hyperglycemia in genetically susceptible individuals. (J. Clin. Invest. 1993 . 92:262-271.) Key words: entrainment * feedback loop * glucose * insulin secretionoscillations * impaired glucose tolerance * non-insulin-dependent diabetes mellitus During the past 10-15 years, many studies have demonstrated that insulin secretion is a complex oscillatory process characterized by rapid oscillations with a periodicity of [8] [9] [10] [11] [12] [13] [14] [15] min, which are superimposed on slower (ultradian) oscillations with a period of 1.5-2 h (1-9). Both rapid and slow oscillations have been observed under fasting conditions and during constant glucose infusion. The ultradian oscillations have in addition been demonstrated during constant enteral nutrition and following meals. The rapid pulses persist in the isolated perfused pancreas ( 10) and in isolated islets ( 11 ) exposed to a constant glucose concentration, suggesting that they occur independently of oscillations in plasma glucose and that they originate due to intraislet mechanisms. The ultradian oscillations in insulin secretion are, by contrast, tightly coupled to glucose (6, 8, 9) . Studies in normal weight subjects during constant glucose infusion and following meals have demonstrated a high degree of concomitance between these secretory oscillations and oscillations in glucose of comparable periodicity. In addition, the periodicity of the insulin secretory oscillations can be entrained to the period of an oscillatory glucose infusion (9) . These findings are entirely compatible with the view that the ultradian oscillations in insulin secretion are a product of the insulin/glucose feedback mechanism (12, 13) .
We have studied the temporal interactions between glucose and insulin secretion by determining the extent to which ultradian oscillations in insulin secretion can be entrained by exogenous glucose. The concept ofentrainment is central to the field of nonlinear dynamics and has been used in many different scientific fields, including the study of biological systems ( 14) . Briefly, ifa nonlinear, self-oscillating system is perturbed exogenously with a periodic stimulus, different types of oscillatory behaviors may emerge, one of which is entrainment. When entrainment occurs, the oscillation of the system reacts to the exogenous stimulus by adjusting its period to that ofthe stimulus. The ability to entrain depends on a number of factors, including the period ofthe stimulus compared with the natural period ofthe system, the amplitude ofthe stimulus, the nonlinearities ofthe system, and the strength ofthe coupling between the exogenous stimulus and the system.
In non-insulin-dependent diabetes mellitus (NIDDM),' the oscillatory pattern of 3-cell secretion is disrupted. The persistent, regular rapid oscillations present in normal subjects are replaced by irregular cycles ofshorter duration both in subjects with established NIDDM and in their first-degree relatives ( 15, 16) . The ultradian oscillations in NIDDM are also more irregular. In addition, they are of smaller amplitude and the propor-in glucose is much smaller ( 17, 18) . These latter observations raise the possibility that specific dynamic properties ofthe feedback loop linking glucose and insulin are disrupted in NIDDM. Such an alteration, ifit could be confirmed, might be indicative of an important early (3-cell abnormality in susceptible individuals even before the onset of overt hyperglycemia. The present study was therefore undertaken to determine ifthe ability to entrain 3-cell secretion was reduced in subjects with established NIDDM and in patients with early impaired glucose tolerance (IGT) who had not yet developed overt hyperglycemia.
Methods

Subjects
Studies were performed in patients with proven NIDDM (n = 7, 6 males, 1 female; 2 Caucasian, 5 Black), impaired glucose tolerance (n = 4, 2 males, 2 females, 1 Caucasian, 3 Black), and in a group of obese subjects (n = 5, 4 males, 1 female, 3 Caucasian, 1 Black, 1 Hispanic) who had normal glucose tolerance and no family history of diabetes. The criteria used to determine whether glucose tolerance was normal or impaired in the respective groups were those of the National Diabetes Data Group (19). The mean age, weight, and body mass index (BMI) of the three groups are demonstrated in Table I . None of the diabetic patients was receiving insulin therapy at the time ofthe study. Oral hypoglycemic agents were discontinued at least 2 wk before the commencement of the experiments.
All studies were performed in the Clinical Research Center (CRC)
ofthe University ofChicago. The protocol was approved by the Institutional Review Board, and all subjects gave written informed consent.
Experimental protocol
Subjects were admitted to the CRC after an overnight fast. After a subject was admitted, an intravenous catheter was inserted into both forearms, one for glucose infusion and one for blood sampling. Beginning at 0800 hours, glucose was infused intravenously for a period of28 h, during which time the subjects remained in the recumbent position. Each study consisted of an initial 4-h period (0800-1200 hours) to allow a steady state to be achieved following the transient glucose rise that is associated with the first few hours ofinitiating a glucose infusion (8). This was followed by a subsequent period of 24 h ( 1200-1200 hours) during which time samples were drawn at 10-min intervals for glucose, insulin, and C-peptide. Lights were dimmed between 2300 and 0700 hours, to allow the subjects to sleep. Potassium (40 meq) was given orally every 12 h, and subjects were allowed free access to water but not given any food for the duration of the experiment. Each subject was studied on at least two occasions under the above protocol. On each occasion, glucose was administered as a 20% solution via a computer-controlled pump (Flo-gard 8000 volumetric infusion pump; Travenol Laboratories, Deerfield, IL) following different patterns. Initially, each subject received a constant glucose infusion at a rate of6 mg/kg per min. The subsequent studies involved the administration ofan oscillatory glucose infusion with periods of96 min and/or 144 min, these periods having been shown to be 20% shorter and 20% longer respectively than the endogenous period observed in normal subjects during constant glucose infusion (9) . The software controlling the glucose infusion was custom written to allow the actual infusion rate to be recorded so that possible interruptions could be detected. Each oscillation was shaped as a sine wave and the amplitude was 33% above and below the mean infusion rate. Subjects received identical volumes of glucose during each 28-h infusion period.
Analytical methods
Blood samples for insulin measurements were allowed to clot at room temperature and the serum was stored at -20'C until assayed. Samples for C-peptide were drawn into tubes at 40C containing 500 Kallikrein inhibitor units/ml Trasylol and 1.2 mg/ml EDTA. The plasma was immediately separated and stored frozen until assayed. Serum insulin was assayed by a double antibody technique (20) . This assay has a lower limit of sensitivity of 20 pmol/liter, and the average intraassay coefficient of variation is 8%. Plasma C-peptide immunoreactivity was measured as previously described (21 ) . The lower limit ofsensitivity of the assay is 0.02 pmol/ml and the intraassay coefficient of variation averages 6%. Plasma glucose was measured with a glucose analyzer (model 23A; Yellow Springs Instrument Co., Yellow Springs, OH). The intraassay coefficient of variation of this method is < 3%.
Data analysis
The relative degree ofinsulin resistance was evaluated with the Homeostasis Model Assessment (HOMA) method (22) , using the mean of 3-4 stressed fasting glucose and insulin levels obtained on different occasions from each subject.
SMOOTHING AND ESTIMATION OF INSULIN SECRETION RATES
The individual glucose, insulin, and C-peptide profiles were smoothed using a three-point moving average as in previous studies ofoscillatory insulin secretion ( 1, 6, 9) . This procedure strongly dampens all fluctuations shorter than 30 min, allowing a better visualization of slower oscillations at an expense of a modest reduction in their amplitude. It also reduces measurement error by a factor of A. All further calculations were performed on the smoothed profiles. The smoothed C-peptide curve was used to derive insulin secretion rates by deconvolution (23) . The kinetic parameters used in the deconvolution program were derived as previously validated and described in detail (24) .
PULSE ANALYSIS
To identify significant pulses, each profile was analyzed with ULTRA, a computer program for pulse detection and quantification (25). The general principle of this algorithm is the elimination of all peaks for which either the increment (difference between the peak and the preceding trough) or the decrement (difference between the peak and the next trough) does not exceed a certain threshold related to measurement error. This produces a so-called "clean" profile. Extensive simulation studies (25) have indicated that a threshold oftwice the intraassay coefficient of variation generally minimizes both false-positive and false-negative errors. This threshold was therefore used to identify significant pulses of glucose. However, because deconvolution involves an amplification of measurement error, a more conservative threshold of three times the intraassay coefficient of variation of C-peptide was used to quantify pulses ofinsulin secretion. In this study, pulse analysis was performed on the profiles smoothed by the three-point moving average so that the measurement errors were reduced by A. Thus peaks of insulin secretion and glucose were considered significant if their respective increments and decrements exceeded 10.39% (i.e., 3 X 6%/ V3) and 3.46% (2 x 3%/ f/), respectively. Peaks that did not meet these threshold criteria were eliminated from the data set using an iterative process. For each significant pulse, the absolute amplitude was defined as the difference between the level of the peak and the level of the preceding trough. Group statistics on pulse amplitudes were based on medians, rather than means, because ofthe non-Gaussian nature of pulse distribution.
Because glucose has a relatively long half-life, changes in production and/or utilization may not be reflected as significant peaks in the glucose concentration curve. We therefore identified all the "shoulders" in the glucose profiles. To do this, instantaneous derivatives ofeach individual clean glucose profile were estimated as the slope ofthe glucose changes during each sampling interval, and the shoulders were identified as slopes with an absolute value of zero (i.e., corresponding to the eliminated peaks), preceded and followed by slopes of the same sign.
analysis of the concomitance. Significant pulses of glucose and insulin secretion were considered concomitant if their peak values occurred within 10 min of each other. The concomitance ratio ofglucose pulses with ISR pulses was calculated as the number of concomitant glucose and ISR pulses divided by the total number of glucose pulses. Conversely, the concomitance ratio of ISR pulses with glucose pulses was calculated as the number of concomitant glucose and ISR pulses divided by the total number of ISR pulses.
Cross-correlation analysis. For each glucose, insulin, and ISR profile a best-fit curve was calculated using a robust algorithm proposed by Cleveland (26) with a window of 15 data points. Each profile was then divided by its corresponding best-fit curve, thereby yielding a detrended profile for which diurnal variations were removed. For each study, coefficients of overall crogs-correlation were then calculated between pairs of detrended profiles (glucose vs. insulin, glucose vs. ISR, and insulin vs. ISR) at lags of 0, ±10, ±20, etc., up to ±300 min. Cross-correlation profiles from different studies were pooled using Fisher's z values (27) . This procedure allowed the maximal coefficient ofcross-correlation for each glucose infusion protocol and study group to be identified along with the lag at which this occurred, thus providing measures ofthe overall concomitance as well as the corresponding lag between the ultradian oscillations in glucose, insulin, and ISR.
Spectral analysis. To investigate the temporal nature ofthe profiles obtained during glucose infusion, spectral analysis was performed on each glucose, insulin, and ISR series. The methods are described by Jenkins and Watts (28) . To remove circadian trends, each series was detrended with the first difference filter, and then spectral estimations were obtained using a Tukey window with a width of 72 data points. Each individual spectrum was normalized assuming the total variance of the series to be 100%. This allowed average values across the three groups to be statistically compared.
STATISTICAL ANALYSIS
Results are expressed as mean±SEM. Statistical tests were performed using the Statistical Analysis System (version 6.04 for personal computers; SAS Institute Inc., Cary, NC). Repeated measures analysis of variance was used to identify overall differences between the three study groups and the studies using the three different glucose infusion protocols. Tukey's studentized range test was used for post-hoc comparisons. Differences were considered to be significant if P < 0.05.
Results
Basal levels ofplasma glucose, serum insulin, and ISR. The clinical characteristics and basal laboratory values of the study groups are recorded in Table I . All three groups were well matched for age, weight, and BMI. Fasting glucose and glycohemoglobin concentrations were significantly higher in the diabetic patients, while these values were normal in the patients 10 .3±1.11 * P < 0.00 1; t P < 0.01 vs. control subjects.
with IGT. Although basal glucose levels were slightly higher in those with IGT compared with the nondiabetic control subjects, the differences were not significant. The differences in the fasting insulin and C-peptide concentrations were not significant at the 5% level. Use ofthe Homeostasis Model Assessment (HOMA) method revealed no significant differences in degree of insulin resistance between the three study groups (control, 8 .0+1.4; IGT, 5.2+0.7; NIDDM, 7.9±1.4; P > 0.43).
Mean 24-h levels of plasma glucose, plasma C-peptide, serum insulin, and ISR. Overall mean concentrations of glucose, insulin, C-peptide, and the insulin secretory rates over the 24-h period during the constant glucose infusion studies are presented in Table II . In addition, the mean glucose levels and insulin secretory rates are shown for the oscillatory studies. Insulin, C-peptide levels, and insulin secretion rates were significantly lower in the NIDDM patients than in the nondiabetic controls, and the glucose concentrations in the NIDDM group were significantly higher than in both the control and IGT groups. The differences in glucose and insulin secretion rates between the patients with IGT and controls were not significant. The glucose levels and insulin secretion rates did not depend on the mode ofglucose infusion. Fig. 1 depicts the mean insulin secretory rates and glucose levels during all studies. The mean glucose levels were elevated and insulin secretion rates were reduced in the subjects with NIDDM compared to controls, with virtually no overlap between the two groups. Patients with IGT tended to have low insulin secretion rates in relation to the prevailing glucose concentration, although the differences in secretion rate did not reach statistical significance.
Number and amplitude ofoscillations. Representative profiles of glucose, insulin and ISR from each of the three study groups during the constant and oscillatory infusions are demonstrated in Figs. [2] [3] [4] . The number and absolute amplitude ofthe respective oscillations in each experimental protocol are shown in Table III and Fig. 5 . The number ofglucose pulses was simi- 144-mmn oscillatory period (P < 0.0001I). There were no significant differences in the amplitude of the glucose oscillations between the three groups. However, differences in the amplitude of the TSR oscillations were highly significant both between the groups (P < 0.001I) and between the glucose infusion protocols (P < 0.01I), and the group differences were related to the differences in the infusion protocols (P < 0.002). Tn the controls, the increase in amplitude of the glucose oscillations brought about by the oscillatory glucose infusion protocols was thus accompanied by a significant increase in the amplitude of the oscillations in TSR, whereas in both the diabetic and TGT groups, the amplitude ofTSR oscillations did not increase significantly with the increase in amplitude of the glucose oscillations (Fig. 5) .
Temporal association between oscillations in glucose and ISR. The temporal association between oscillations in glucose and TSR was evaluated using three separate approaches: pulse-
by-pulse analysis of concomitance, cross-correlation analysis, and spectral analysis. Each approach to the analysis of the data indicated a reduction in the normal tight temporal coupling between oscillations in glucose and TSR in the NIDDM and IGT subjects although the significance of the differences varied depending on the technique.
Pulse-by-pulse analysis of concomitance. The concomitance between individual pulses of glucose and TSR for each group and protocol are shown in Table ITT . When the concomitance of pulses in TSR with glucose pulses was examined with repeated measures two-way analysis of variance, there was a significant difference between groups (NIDDM significantly different from TGT and control; P < 0.002) and between glucose infusion protocols (P < 0.0002). Similarly, the percentage of glucose pulses that was concomitant with an TSR pulse was significantly different between groups (NIDDM significantly different from control; P < 0.03), but not between glucose infusion protocols. In order to determine if these differences were confirmed with other analytical approaches, cross-correlation and spectral analyses were applied.
Cross-correlation analysis. Fig. 6 illustrates the coefficient of cross-correlation between glucose and TSR at different lags for the three groups and the three glucose infusion protocols. Repeated measures two-way analysis of variance showed that the maximal coefficient of cross-correlation between glucose and TSR was different between the three groups (TGT and NTDDM different from control; P < 0.0001I) and between the three glucose infusion protocols (P < 0.002). Similarly, the maximal coefficients of cross-correlation between glucose and insulin were different between the groups (TGT and NTDDM different from control; P < 0.001I) and between the three glucose infusion protocols (P < 0.002). The results for correlation between TSR and insulin were only significant between the groups (NTDDM different from control; P < 0.04). Tn order to examine which of the three glucose infusion protocols most clearly brought out group differences, one-way analysis of variance was performed on data from each glucose infusion study separately. The 144-mmn protocol consistently revealed the most significant differences. In addition to reduced overall Figure 3 . Profiles of the glucose infusion rate, the glucose and insulin concentrations, and the insulin secretory rates in one representative IGT patient. All three studies performed in this patient are shown: constant glucose infusion, left; slow oscillatory infusion, middle; rapid oscillatory infusion, right. A few interruptions occurred that were all of short duration (< 2 min), and they did not have any visible effect upon the glucose profiles.
cross-correlation, the NIDDM group also demonstrated a considerably increased lag at which the maximal coefficient was observed (see Fig. 6 ). In other words, while the overall coefficient ofcross-correlation between glucose and ISR was greatest at a lag of zero min in the control and IGT groups for all glucose infusion protocols, there was a lag in the NIDDM group which ranged from 15 to 35 min (peaks ofglucose occurring before peaks of ISR) depending on the glucose infusion protocol. Similar results were obtained for the cross-correlation between glucose and insulin. Spectral analysis. Spectral analysis of the oscillatory profiles (Fig. 7) confirmed the existence of peaks in the plasma glucose spectra in the three study groups at 96 and 144 min, corresponding to the respective periods of the exogenous infusion. Similar spectral peaks in insulin (not shown) and ISR were observed in the nondiabetic control subjects. However any discrepancy between insulin and ISR. In these individuals, the largest spectral peak was always observed at the corresponding period of the exogenous glucose infusion. Examples of individual spectra illustrating these results are shown in Fig. 8 .
changes to assume the period of exogenous pulses of glucose during exogenous oscillatory glucose infusions. Thus these ultradian oscillations in insulin secretion were completely entrainable by exogenous glucose, implying that the inherent
Discussion
We have previously demonstrated that in normal volunteers properties of the insulin/glucose feedback loop play an important role in regulating and generating the oscillations.
The present study was designed to determine if specific dynamic abnormalities are present in the feedback loop linking insulin secretion and glucose in NIDDM during constant and oscillatory intravenous glucose infusion. Studies were performed in patients with overt NIDDM and matched groups with impaired and normal glucose tolerance who received intravenous glucose infusions either at a constant or oscillatory rate with a periodicity of 96 or 144 min. In all three groups, oscillations in glucose and ISR were apparent during constant glucose infusion. In the group with normal glucose tolerance a tight temporal coupling was evident between the oscillations ofglucose and ISR. In contrast, in patients with IGT and NIDDM, there was evidence of uncoupling of this relationship between glucose and ISR and many glucose independent oscillations were apparent. Alterations in the ultradian oscillations in ISR have not previously been characterized in subjects with IGT. The abnormal relationship between oscillations ofglucose and ISR in this particular group, which is similar to that observed in the NIDDM group, suggests that an uncoupling of the temporal association between ultradian oscillations in glucose and ISR is an early manifestation of,-cell dysfunction in NIDDM.
In these studies, evidence for lack of control by glucose of the ultradian oscillations of ISR was demonstrated using three different analytical approaches ( 12) may provide an initial framework with which to address these questions. In this model, the maintenance of the regular pattern of oscillatory secretion observed in normal subjects was dependent on a number of factors, the most important of these being the simple sigmoidal relationship between glucose and insulin secretion, the existence of a time delay in the order of 25-50 min between the increase in insulin secretion and the suppression of hepatic glucose production, and the fact that insulin must diffuse into a remote peripheral compartment before stimulating peripheral glucose utilization. Alterations in the dose-response relationship between glucose and insulin secretion (34-38), hepatic resistance to the action of insulin (39-43), or prolonged time lags in the periphery due to diminished glucose disposal (42) could all contribute to the alterations in the dynamic interactions between insulin secretion and glucose observed in the IGT and NIDDM groups in this study. To understand fully the lack of entrainment observed in these groups, however, it may be necessary to modify the model to include factors other than the insulin/glucose feedback mechanism.
The present study also highlights the systematic change in (-cell secretory responses as obesity progresses to IGT and ultimately NIDDM. In Table TI , the mean 24-h insulin and C-peptide concentrations as well as the mean insulin secretory rates in the IGT group are intermediate between those observed in the obese and NIDDM groups. The data in Table III demonstrate a progressive decline in the absolute amplitude of the glucose and ISR pulses with the transition from obesity to IGT to NIDDM. The similarity in basal insulin and C-peptide levels between the NIDDM and IGT groups in Table I (both ofwhich were lower than the corresponding concentrations in the obese
[nondiabetic] subjects) raises the possibility that (3-cell secretory function decreases before the development ofsevere hyperglycemia in NIDDM. This is further illustrated in Fig. 1 , depicting the relationship between mean glucose concentration and mean rates of insulin secretion throughout the 24-h study where the insulin secretory responses in many of the IGT and NIDDM subjects were not different despite the marked differences in glucose levels. In this regard, it is also ofinterest that all three methods used to analyze the interaction between glucose and insulin secretion demonstrated abnormalities in the patients with IGT that were qualitatively similar but less severe than the defects identified in the subjects with NIDDM. It is therefore possible that the uncoupling of the ISR and glucose oscillations is a key factor in the development ofglucose intolerance in susceptible individuals. The lower association observed by both cross-correlation and spectral analysis between the patterns of insulin and ISR oscillations in the IGT and NIDDM groups than in the control group is not readily explained in view of the equimolar secretion of insulin and C-peptide from the (-cell, which has been well documented (44) (45) (46) . In contrast to nondiabetic subjects, NIDDM patients have elevated levels of proinsulin and of proinsulin conversion intermediates (split proinsulins), suggesting that the (-cell in this instance releases immature secretory granules into the circulation (47) (48) (49) (50) (51) (52) . Since conventional insulin radioimmunoassays cross-react with proinsulin, it is also possible that the dissociation observed between insulin and ISR in the NIDDM and IGT groups can be attributed in part to oscillating proportions of proinsulin secretion in relation to the secretion ofinsulin. Proinsulin concentrations were not, however, measured in these experiments.
Although (-cell entrainment was preserved in obesity, the present study raises the possibility that obese subjects may have subtle abnormalities in (3-cell function. Previous studies in obese individuals quantitating insulin secretion rates and evaluating pulsatility following meals have demonstrated (3-cell secretory patterns to be similar to those observed in normal weight subjects (7, 53) . In the present study, detailed analysis of the proportion of ISR pulses that were concomitant with pulses in glucose yielded concomitance ratios of 66% and 80% in the 96 min and 144 min oscillatory infusions, respectively. This contrasts with concomitance ratios exceeding 90% that were previously reported for younger, normal weight subjects (9) studied under identical experimental protocols. The obese subjects in this study were however older and presumably more insulin resistant than the normal weight subjects studied previously. Additional studies are currently under way to determine if these differences could be due to the different ages of the subjects, and/or differences in weight and degree of insulin resistance. In light of the importance of the insulin/glucose feedback mechanism in controlling the oscillations in nondiabetic subjects, the notion that insulin resistance may, together with intrinsic defects in the ( cell, contribute to alterations in ultradian oscillations is an intriguing possibility that should be systematically addressed in future studies.
In conclusion, the present study demonstrates that the insulin/glucose feedback mechanism, which plays an important role in the regulation and generation of the ultradian oscillations in nondiabetic subjects, is disrupted in NIDDM and even in conditions where glucose tolerance is only minimally impaired. The resultant uncoupling of the normal tight relationship between glucose and ISR pulses is reflected in a reduction in the spectral power of the ultradian oscillations of insulin secretion when oscillatory glucose is administered and in a dis-crepancy between the dominant period ofthe spectra ofinsulin secretion and glucose. Similar changes are seen using crosscorrelation analysis and pulse analysis. The dissociation between the oscillations becomes more severe with the progression from impaired glucose tolerance to NIDDM. Whether the abnormal secretory oscillations play a pathogenetic role in the progression to overt diabetes or whether they are merely reflective of underlying defects in the : cell and peripheral tissues remains to be determined.
